Skip to main content

Advertisement

Log in

The management of hydronephrosis in patients undergoing TURBT

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective: Previous studies have shown the negative prognostic correlation of hydronephrosis in bladder cancer; however, practical uncertainties remain regarding the management of these patients. Methods: We retrospectively reviewed the notes of patients undergoing TURBT over a three year period and recorded the management and outcome of patients with hydronephrosis. Results: Six percent with bladder cancer had hydronephrosis. Nearly all the cases had muscle invasive disease. At TURBT, the ureteric orifice was seen in 41%; in the remaining 59% of patients, the ureteric orifice was involved and resected. This resolved the hydronephrosis in only one patient (who had superficial disease). Conclusions: Hydronephrosis in bladder cancer is associated with a poor prognosis. The hydronephrosis does not resolve with resection alone. As awaiting it’s resolution may delay definitive treatment, we suggest aggressive management of hydronephrosis from the time of initial diagnosis with ureteric stenting in order to protect renal units and optimize renal function prior to further definitive treatment of bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nichols JA and Marshall VF (1956). The treatment of bladder carcinoma by local excision and fulguration. Cancer 9: 559–565

    Article  PubMed  CAS  Google Scholar 

  2. Lang EK and Nourse M (1969). The roentgenographic diagnosis of obstructive lesions of the ureter. J Urol 101: 812–20

    PubMed  CAS  Google Scholar 

  3. Haleblian GE, Skinner EC and Dickinson MG (1998). Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol. 160: 2011–2014

    Article  PubMed  CAS  Google Scholar 

  4. Hatch TR and Barry JM (1986). The value of excretory urography in staging bladder cancer. J Urol 135: 149

    Google Scholar 

  5. Leibovitch I and Ben-Chaim J (1993). The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder. J Surg Oncol 52: 31–35

    Article  PubMed  CAS  Google Scholar 

  6. Sobin LH and Wittekind C (2002). TNM classification of malignant tumours. Wiley-Liss, New York

    Google Scholar 

  7. Takashi M, Murase T and Mizuno S (1987). Multivariate evaluation of prognostic determinants in bladder cancer patients. Urol Int 42: 368–374

    Article  PubMed  CAS  Google Scholar 

  8. Kottmeier HL (1967). Presentation of therapeutic results in carcinoma of the female pelvis: experience of the Annual Report on the Results of Treatment in Carcinoma of the Uterus, Vagina and Ovary. Gynecol Oncol. 4: 13–19

    Article  Google Scholar 

  9. Iliya FA, O’Leary JA and Frick HC (1966). Prognostic significance of ureteral obstruction in carcinoma of the cervix. Cancer 19: 689–690

    Article  PubMed  CAS  Google Scholar 

  10. Bowles WT and Silber I (1972). Carcinoma of the bladder: a computer analysis of 516 patients. J Urol 107: 245–247

    PubMed  CAS  Google Scholar 

  11. Greiner R, Skaleric C and Veraguth P (1977). The prognostic significance of ureteral obstruction in carcinoma of the␣bladder. Int J Radiat Oncol Biol Phys 2: 1095–1100

    PubMed  CAS  Google Scholar 

  12. Mahoney EM, Weber ET and Harrison JH (1975). Post-diversion pre-cystectomy irradiation for carcinoma of the bladder. J Urol 114: 46–49

    PubMed  CAS  Google Scholar 

  13. Golding RP and Tierie AH (1987). Intravenous urography as a prognostic indicator in vesical carcinoma. Cancer 60: 883–886

    Article  PubMed  CAS  Google Scholar 

  14. Shipley WU, Rose MA and Perrone TL (1985). Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol 134: 679–683

    PubMed  CAS  Google Scholar 

  15. See WA (2000). Distal ureteral regeneration after radical transurethral bladder tumor resection. Urology 55: 212–215

    Article  PubMed  CAS  Google Scholar 

  16. Connolly JG, Morales A, Minnaker L and Raeburn H (1971). The origin of regenerative bladder mucosa after partial mucosal stripping. Invest Urol 8: 481–487

    PubMed  CAS  Google Scholar 

  17. Robinson P, Collins CD, Ryder WD, Carrington BM, Hutchinson CE and Bell D (2000). Relationship of MRI and clinical staging to outcome in invasive bladder cancer treated by radiotherapy. Clin Radiol 55: 301–306

    Article  PubMed  CAS  Google Scholar 

  18. Hussain SA, Moffitt DD and Glaholm JG (2001). A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer. Ann Oncol. 12: 929–935

    Article  PubMed  CAS  Google Scholar 

  19. Hussain SA, Stocken DD and Peake DR (2004). Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer. Br J Cancer 90: 2106–2111

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N Thiruchelvam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiruchelvam, N., Ubhayakar, G. & Mostafid, H. The management of hydronephrosis in patients undergoing TURBT. Int Urol Nephrol 38, 483–486 (2006). https://doi.org/10.1007/s11255-005-4794-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-005-4794-9

Keywords

Navigation